Helping breast cancer survivors manage their fear of cancer returning
Randomized controlled trial of FoRtitude: Targeted eHealth intervention to reduce fear of recurrence among breast cancer survivors in community oncology settings
This study is testing a helpful online program called FoRtitude, designed to support breast cancer survivors in managing their fear of the cancer coming back, using friendly tools and strategies over four weeks.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10980062 on NIH RePORTER |
What this research studies
This research focuses on developing an eHealth intervention called FoRtitude, aimed at helping breast cancer survivors cope with their fear of recurrence (FoR). The program utilizes cognitive behavioral therapy (CBT) strategies delivered through an online platform, making it accessible and scalable for patients. Participants will engage with interactive tools and didactic content over four weeks, with additional support through motivational interviewing to enhance adherence. The goal is to provide effective coping mechanisms for survivors facing emotional and cognitive challenges after treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are breast cancer survivors experiencing moderate to severe fear of recurrence.
Not a fit: Patients who are currently undergoing active cancer treatment or those without significant fear of recurrence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the fear of cancer recurrence among breast cancer survivors, improving their overall quality of life.
How similar studies have performed: Previous research has shown promising results with similar eHealth interventions for managing psychological distress in cancer survivors.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Wagner, Lynne I. — Univ of North Carolina Chapel Hill
- Study coordinator: Wagner, Lynne I.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.